Issue 2 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

32

No.

2

January 20, 2006Jan 20, 2006

Free

DOWNLOAD THE PDF

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

NCI Clinical Alert Urges Patients To Seek Care From Specialists.

FDA Revises Package Insert, Seeks To Limit Product Liability Suits In State Courts.

Senate Committee Investigating Pharma’s “Educational Grants.”

Recent Issues

Volume 52 | Issue 37 - October 09, 2026

Volume 52 | Issue 36 - October 02, 2026

Volume 52 | Issue 35 - September 25, 2026

Volume 52 | Issue 34 - September 18, 2026

Volume 52 | Issue 33 - September 11, 2026

Volume 52 | Issue 32 - August 14, 2026